5-hydroxytryptophan has been researched along with Cancer of Prostate in 1 studies
5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kälkner, KM | 1 |
| Ginman, C | 1 |
| Nilsson, S | 1 |
| Bergström, M | 1 |
| Antoni, G | 1 |
| Ahlström, H | 1 |
| Långström, B | 1 |
| Westlin, JE | 1 |
1 other study available for 5-hydroxytryptophan and Cancer of Prostate
| Article | Year |
|---|---|
Positron emission tomography (PET) with 11C-5-hydroxytryptophan (5-HTP) in patients with metastatic hormone-refractory prostatic adenocarcinoma.
Topics: 5-Hydroxytryptophan; Adenocarcinoma; Aged; Bone Neoplasms; Carbon Radioisotopes; Humans; Male; Middl | 1997 |